StatStrip Gen 2.0 hospital glucose meter recall: results may go to wrong patient

The study

This is not a clinical study. It is a safety communication from the US FDA (MedWatch), published on 2026-10-30, about a correction to the StatStrip Glucose Hospital Meter System made by Nova Biomedical. The FDA has identified the recall as the most serious type. It states that the device may cause serious injury or death if used without correction.

Only the newest model, the StatStrip Glucose Hospital Meter Gen 2.0, is affected. The notice says previously released models are not affected.

What they found

Nova Biomedical has received customer reports of a scanning problem. When a patient ID or Quality Control (QC) barcode is scanned, prior information may remain on the meter screen. If the user accepts it, the glucose result is assigned to the wrong patient's medical record or QC ID.

Nova Biomedical states that the problem affects Gen 2.0 meters on all firmware versions. It also states that the analytical performance of glucose measurement is not affected.

The notice warns that clinicians may act on another patient's glucose result. This could cause delayed treatment, unnecessary treatment (including inappropriate insulin administration) or failure to treat the intended patient. Harm depends on the patient's actual glucose status and clinical condition. Critically ill patients and infants are at greater risk, because they may be unable to communicate symptoms of hypoglycaemia.

As of October 5, Nova Biomedical had reported one serious injury and no deaths linked to this issue. It sent an initial letter to affected customers on July 31 and an updated letter on October 5. It has put a shipment hold on all new Gen 2.0 meters. A software update is planned for November 2026, to be rolled out in phases.

The recommended actions are:

• Where the electronic medical record has integrated Admission, Discharge and Transfer (ADT) information, tick "Validate Patient ID's" in NovaNet.
• Set the meters to log the operator out after each test.
• After every barcode scan, check that the patient name, date of birth and other identifiers match the patient being tested before pressing Accept.
• Check the patient ID again on the result screen. Do not assume it is the same as at scanning.
• Notify the administrator at once if any glucose level is assigned to the wrong patient, and flag or remove the result in the record so it is not used for glucose management decisions.

How much weight to give it

This is a regulatory notice based on customer reports. It is not a trial or a measured error rate. The notice does not say how many meters are affected or how often the fault occurs. The one serious injury reported as of October 5 shows that harm has been reported, but it does not show how common it is.

The software fix is still being verified and validated. Its effect has not yet been shown. The mitigation steps depend on staff checking carefully at every test, and the notice does not report how well they work in practice.

For your clinic

This notice is from the US FDA. It does not say whether the affected meters are used in India. Hospitals that use StatStrip Gen 2.0 meters should check the model with their biomedical or laboratory teams.

If these meters are in use, the full FDA notice and the Nova Biomedical customer advisory should be read first. Note that the instruction to stop using the meter applies where an alternative meter is available. Nursing and point-of-care staff may need a reminder to verify patient identity on both the scan screen and the result screen.

The notice also gives steps for a result found to be wrongly assigned. It should be flagged or removed straight away, so that other healthcare providers do not use it for glucose management decisions. The facility's usual procedures for correcting erroneous entries in the medical record should be followed, and the treating clinical team should be told promptly.